Epsilon Healthcare Limited Stock Fundamentals
| HDRPF Stock | USD 0 0.00 0.00% |
Epsilon Healthcare Limited fundamentals help investors to digest information that contributes to Epsilon Healthcare's financial success or failures. It also enables traders to predict the movement of Epsilon Pink Sheet. The fundamental analysis module provides a way to measure Epsilon Healthcare's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Epsilon Healthcare pink sheet.
Epsilon |
Epsilon Healthcare Limited Company Profit Margin Analysis
Epsilon Healthcare's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Epsilon Healthcare Profit Margin | (2.41) % |
Most of Epsilon Healthcare's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Epsilon Healthcare Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Epsilon Healthcare Limited has a Profit Margin of -2.4105%. This is 78.5% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The profit margin for all United States stocks is 89.8% higher than that of the company.
Epsilon Healthcare Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Epsilon Healthcare's current stock value. Our valuation model uses many indicators to compare Epsilon Healthcare value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Epsilon Healthcare competition to find correlations between indicators driving Epsilon Healthcare's intrinsic value. More Info.Epsilon Healthcare Limited is rated # 3 in return on equity category among its peers. It is rated # 4 in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Epsilon Healthcare's earnings, one of the primary drivers of an investment's value.Epsilon Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Epsilon Healthcare's direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Epsilon Healthcare could also be used in its relative valuation, which is a method of valuing Epsilon Healthcare by comparing valuation metrics of similar companies.Epsilon Healthcare is currently under evaluation in profit margin category among its peers.
Epsilon Fundamentals
| Return On Equity | -0.81 | |||
| Return On Asset | -0.14 | |||
| Profit Margin | (2.41) % | |||
| Operating Margin | (1.12) % | |||
| Current Valuation | 6.57 M | |||
| Shares Outstanding | 300.35 M | |||
| Shares Owned By Insiders | 28.06 % | |||
| Shares Owned By Institutions | 0.03 % | |||
| Price To Book | 0.90 X | |||
| Price To Sales | 1.10 X | |||
| Revenue | 5.5 M | |||
| Gross Profit | 1.92 M | |||
| EBITDA | (8.01 M) | |||
| Net Income | (9.24 M) | |||
| Cash And Equivalents | 2.34 M | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 4.44 M | |||
| Debt To Equity | 0.23 % | |||
| Current Ratio | 1.10 X | |||
| Book Value Per Share | 0.04 X | |||
| Cash Flow From Operations | (5.43 M) | |||
| Earnings Per Share | (0.03) X | |||
| Beta | 1.22 | |||
| Market Capitalization | 5.42 M | |||
| Total Asset | 30.37 M | |||
| Z Score | 0.6 | |||
| Net Asset | 30.37 M |
About Epsilon Healthcare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Epsilon Healthcare Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Epsilon Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Epsilon Healthcare Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Epsilon Healthcare Limited operates as a healthcare and pharmaceuticals company primarily in Australia and Canada. Epsilon Healthcare Limited was incorporated in 2016 and is based in Sydney, Australia. Epsilon Healthcare operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.
Currently Active Assets on Macroaxis
Other Information on Investing in Epsilon Pink Sheet
Epsilon Healthcare financial ratios help investors to determine whether Epsilon Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Epsilon with respect to the benefits of owning Epsilon Healthcare security.